Clinical trial
Safety of Celecoxib in Patients With Crohn's Disease
NCT00177866 · University of Pittsburgh, Other · Terminated
Key facts
| NCT number | NCT00177866 |
|---|---|
| Title | Safety of Celecoxib in Patients With Crohn's Disease |
| Official title | The Safety of Celecoxib (Celebrex) in Patients With Crohn's Disease |
| Lead sponsor | University of Pittsburgh, Other |
| Collaborators | Shadyside Hospital Foundation Pfizer Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Crohn's Disease |
| Intervention type | Drug |
| Interventions | Celebrex, placebo |
| Enrollment | 28 |
| Start date | Dec 1, 2003 |
| Primary completion | Jun 1, 2010 |
| Completion | Jun 1, 2010 |
| First posted | Sep 15, 2005 |
| Last update posted | Aug 29, 2016 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: